This coming weekend Dr. John Buse, M.D., Ph.D., takes his place as president of the American Denialbetes Association (ADA) gathering in Chicago for their 67th annual meetings.

Dr. Buse was one of the first to speak out in defense of the diabetic drug Avandia a few weeks ago after reports of increased heart attacks and heart deaths by diabetics using that drug compared to those using other diabetic drugs.

“A lot of people just freak out. But there’s no cause for panic,” said Buse of the drug Avandia.

Did I mention that the ADA is heavily financed by pharmaceutical companies?

The day following the “no panic” remark of President Buse it was reported that he had cited, “a worrisome trend in cardiovascular deaths and severe adverse events” among patients using Avandia in a letter he sent more than seven years ago in the year 2000 to the FDA. That letter was not many months after the drug was first approved.

As it turns out ADA President Buse had discovered these findings and presented them at national scientific meetings before the drug entered the marketplace in 1999.

The incoming ADA President testified in Congressional hearings two weeks ago, “The chairman of my department told me that out of respect for a long-standing academic colleague who now had a senior position at SKB, he had agreed to discuss with me the presentations that I had made and how they had been characterized.”

Reportedly there were threats of a $4 billion dollar lawsuit possibility against Buse for the potential financial loss due to his speaking out on his Avandia findings that were similar in 1999 to those reported only a few weeks ago.

“In the end I offered to help the company with further studies and signed a clarifying statement drafted by SKB which was to be used to with the investment community,” ADA President Buse testified two weeks ago in Congressional hearings.

Did I mention that Buse’s employer, the University of North Carolina (UNC) where he is a professor at their medical school received funding from the maker of Avandia and other pharmaceutical companies?

Did I mention Buse’s own testimony about pharmaceutical phunding to “support the operation of the UNC Diabetes Care Center which I direct”?

The Nuremberg War Crimes trials defense of “I was only following orders” did not keep those who used it from prison or even the gallows. Those included medical experimenters.

Dr. John Buse, M.D., Ph.D., is being made President of the ADA.

Near the end of Buse’s congressional testimony he said that he wanted to “be fair” and said that “there is no currently available treatment for elevated blood sugar with proven benefits to reduce the risk of heart attack.”

This is a very clever use of words and facts. While none of the other diabetic drugs help the heart at the same time none of them are worse for increasing the risks of heart attack and heart deaths than Avandia.

Did I mention that the mineral chromium in the correct form – that which is grown – is helpful for both elevated blood sugar and for the heart? I haven’t found anywhere that Dr. Buse or any of his ADA cohorts have mentioned this.

Something rotten in the state of Denmark?

What is the legacy of the ADA after 67 years and countless billions of dollars? Diabetes spiraling into an out of control epidemic in more and younger people all the time is their legacy.

Meanwhile this week a study from the National Changing Diabetes Program (NCDP) made a presentation to Congress for a federal diabetes program after noting that more than 10 per cent of all federal health care spending is related to diabetes.

Did I mention that NCDP is funded by Denmark’s Novo Nordisk, one of the world’s largest sellers of insulin and diabetic products going back more than 80 years?

Is it flaky for a Danish company puffed up with profits from diabetes to want U.S. government federalization of diabetes?

How about if the U.S. government just started to enforce the Pure Food & Drug Act of 100 years ago by stopping the near total removal of the abundance of the mineral chromium from whole sugar and whole grain flour? The end products of bleached white, refined sugars and flours constitutes more than one third of the average American diet.

The cost of such enforcement would be a much greater value and benefit than another new pfederal program for more money for more drugs.